TABLE 2.
Characteristic | Value |
---|---|
No. (%) of patients with the following donor type: | |
MFD | 4 (21) |
PMFD | 10 (52.6) |
MUD | 5 (26.3) |
No. (%) of patients with the following GVHD prophylaxis during ISA treatment: | 10 (52.6) |
Cyclosporine | 5 |
Sirolimus | 2 |
Tacrolimus | 1 |
Methylprednisolone | 2 |
No. (%) of patients with the following aGVHD grade: | |
I-II | 4 |
III-IV | 2 |
Abbreviations: MFD, matched family donor; PMFD, partially matched family donor; MUD, matched unrelated donor; aGVHD, acute graft-versus-host disease; GVHD, graft-versus-host disease.